B-Type Natriuretic Peptide to Predict Ductus Intervention in Infants <28 Weeks
- 1 September 2008
- journal article
- Published by Springer Nature in Pediatric Research
- Vol. 64 (3), 286-290
- https://doi.org/10.1203/pdr.0b013e3181799594
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Periventricular Hemorrhagic Infarction: Risk Factors and Neonatal OutcomePediatric Neurology, 2006
- Patent Ductus Arteriosus, Indomethacin and Necrotizing Enterocolitis in Very Low Birth Weight Infants: A Population-Based StudyJournal of Pediatric Gastroenterology and Nutrition, 2005
- Treatment of patent ductus arteriosusSeminars in Neonatology, 2003
- Cardiocirculatory effects of patent ductus arteriosus in extremely low‐birth‐weight infants with respiratory distress syndromePediatrics International, 2003
- Placental and Other Perinatal Risk Factors for Chronic Lung Disease in Very Low Birth Weight InfantsPediatric Research, 2002
- Long-Term Effects of Indomethacin Prophylaxis in Extremely-Low-Birth-Weight InfantsNew England Journal of Medicine, 2001
- Early ductal shunting and intraventricular haemorrhage in ventilated preterm infants.Archives of Disease in Childhood: Fetal & Neonatal, 1996
- Changing trends in the epidemiology and pathogenesis of neonatal chronic lung diseaseThe Journal of Pediatrics, 1995
- Diagnosis of patent ductus arteriosus in the preterm newborn.Archives of Disease in Childhood, 1993
- Patent Ductus Arteriosus, Indomethacin, and Intestinal Distension: Effects on Intestinal Blood Flow and Oxygen ConsumptionPediatric Research, 1991